Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Merck did not respond to a request for comment.
Simplified Text
Merck did not respond to the author's request for comment.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "organization": "Merck"
}
Subject Tags
Business Pharmaceuticals
UUID
e70d8c5d-63b3-4a69-a192-905f55979a79
Vector Index
✗ No vector
Created
September 18, 2026 at 7:09 PM (3 weeks ago)
Last Updated
September 18, 2026 at 7:09 PM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/17/well/ai-drug-discovery-stanford.html
A.I. Agents as ‘Co-Scientists’? This Lab Says They Could Speed Drug Research.
Completed News
19 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/17/well/ai-drug-discovery-stanford.html

Researchers at Stanford University are developing A.I. "co-scientists" to rapidly accelerate drug discovery by independently generating hypotheses and running computer-based experiments. This approach has already shown promising results in Covid-19 vaccine redesign and lung cancer drug target identification.

Artificial Intelligence Drug Discovery Biomedical Research Stanford University COVID-19 Cancer Research Machine Learning

Similar Claims (5)

Other claims identified as semantically similar to this one.